Ireland putting systems in place as it heads towards generic substitution
This article was originally published in Scrip
Executive Summary
The Irish Medicines Board (IMB) is keen to increase the voluntary reporting of adverse events by healthcare professionals across the country, as Ireland moves to introduce a system of generic substitution sometime next year.